In late years the prevalence of the Japanese cedar pollinosis increases in 26%, and importance of allergic rhinitis treatment increases more and more. We got possible to conduct standard treatment based on a guideline. However, the satisfaction of patients with pollinosis has a report not to be high at all. When it aims for a high medical care of the patients satisfaction, it is important to evaluate a therapy objectively. Standard QOL (Quality of life) questionnaire for the allergic rhinitis (JRQLQ) was completed in 2002. We can compare degree of improvement degree of the QOL if we use this QOL questionnaire. Also, the reduction of the labor productivity due to the allergic rhinitis is recognized as a social issue, too.
As new therapy for Japanese cedar pollinosis, sublingual immunotherapy attracts attention. After 2003, clinical studies were conducted led by a research group of Ministry of Health, Labour and Welfare. Improvement of the QOL of patients with allergic rhinitis and improvement of the satisfaction are expected by the development of the new regimen advancing.